LUMN vs. CLOV

Last updated Apr 1, 2026

Compare and contrast key facts about Lumen Technologies, Inc. (LUMN) and Clover Health Investments, Corp. (CLOV).

Performance

LUMN vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lumen Technologies, Inc. (LUMN) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

LUMN vs. CLOV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
LUMN Lumen Technologies, Inc.	-10.55%	46.33%	190.16%	-64.94%	-55.48%	38.82%	1.26%
CLOV Clover Health Investments, Corp.	-25.11%	-25.40%	230.85%	2.43%	-75.01%	-77.82%	64.41%

Fundamentals

Market Cap LUMN : $6.92B CLOV : $910.34M
EPS LUMN : -$1.75 CLOV : -$0.17
PS Ratio LUMN : 0.56 CLOV : 0.47
Total Revenue (TTM) LUMN : $12.40B CLOV : $1.92B
Gross Profit (TTM) LUMN : $3.02B CLOV : $1.99B
EBITDA (TTM) LUMN : $1.32B CLOV : -$83.86M

Returns By Period

In the year-to-date period, LUMN achieves a -10.55% return, which is significantly higher than CLOV's -25.11% return.

LUMN

• 1D: 8.76%
• 1M: -2.25%
• YTD: -10.55%
• 6M: 13.56%
• 1Y: 77.30%
• 3Y*: 37.90%
• 5Y*: -9.69%
• 10Y*: -8.87%

CLOV

• 1D: 2.33%
• 1M: -15.79%
• YTD: -25.11%
• 6M: -42.48%
• 1Y: -50.97%
• 3Y*: 27.70%
• 5Y*: -24.93%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LUMN vs. CLOV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LUMN

LUMN Risk / Return Rank: 73
LUMN Sharpe Ratio Rank: 74
LUMN Sortino Ratio Rank: 75
LUMN Omega Ratio Rank: 72
LUMN Calmar Ratio Rank: 73
LUMN Martin Ratio Rank: 70

CLOV

CLOV Risk / Return Rank: 9
CLOV Sharpe Ratio Rank: 10
CLOV Sortino Ratio Rank: 10
CLOV Omega Ratio Rank: 12
CLOV Calmar Ratio Rank: 6
CLOV Martin Ratio Rank: 6

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LUMN vs. CLOV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lumen Technologies, Inc. (LUMN) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LUMN	CLOV	Difference
Sharpe ratio Return per unit of total volatility	0.96	-0.78	+1.73
Sortino ratio Return per unit of downside risk	1.80	-1.06	+2.86
Omega ratio Gain probability vs. loss probability	1.22	0.87	+0.35
Calmar ratio Return relative to maximum drawdown	1.61	-0.93	+2.54
Martin ratio Return relative to average drawdown	3.38	-1.69	+5.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LUMN vs. CLOV - Sharpe Ratio Comparison

The current LUMN Sharpe Ratio is 0.96, which is higher than the CLOV Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of LUMN and CLOV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LUMN	CLOV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.96	-0.78	+1.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.12	-0.28	+0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.13	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	-0.31	+0.46

Correlation

The correlation between LUMN and CLOV is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LUMN vs. CLOV - Dividend Comparison

Neither LUMN nor CLOV has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LUMN Lumen Technologies, Inc.	0.00%	0.00%	0.00%	0.00%	14.37%	7.97%	10.26%	7.57%	14.26%	12.95%	9.08%	8.59%
CLOV Clover Health Investments, Corp.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

LUMN vs. CLOV - Drawdown Comparison

The maximum LUMN drawdown since its inception was -95.26%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for LUMN and CLOV.

Drawdown Indicators

	LUMN	CLOV	Difference
Max Drawdown Largest peak-to-trough decline	-95.26%	-97.19%	+1.93%
Max Drawdown (1Y) Largest decline over 1 year	-47.34%	-54.97%	+7.63%
Max Drawdown (5Y) Largest decline over 5 years	-92.86%	-97.19%	+4.33%
Max Drawdown (10Y) Largest decline over 10 years	-94.53%	—	—
Current Drawdown Current decline from peak	-66.37%	-92.05%	+25.68%
Average Drawdown Average peak-to-trough decline	-27.51%	-76.30%	+48.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.62%	30.15%	-7.53%

Volatility

LUMN vs. CLOV - Volatility Comparison

Lumen Technologies, Inc. (LUMN) has a higher volatility of 14.72% compared to Clover Health Investments, Corp. (CLOV) at 11.60%. This indicates that LUMN's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LUMN	CLOV	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.72%	11.60%	+3.12%
Volatility (6M) Calculated over the trailing 6-month period	61.76%	47.49%	+14.27%
Volatility (1Y) Calculated over the trailing 1-year period	81.10%	65.84%	+15.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	84.24%	89.37%	-5.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	66.93%	86.00%	-19.07%

Financials